Who has invested in Huisheng Biopharmaceutical?

China Life Private Equity Investment, Tianjin Grand Flight Yongxuan, Tianjin Grand Flight Jimao, Ginkgo Capital are named among the investors backing Huisheng Biopharmaceutical.

Huisheng Biopharmaceutical Funding: $70M Raised, Series A

Huisheng Biopharmaceutical funding overview

Huisheng Biopharmaceutical is based in Zhangjiawan, Beijing, China. Huisheng Biopharmaceutical has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2022. The round record for Huisheng Biopharmaceutical runs through 2022; nothing later has been disclosed. Investors on record include China Life Private Equity Investment, Tianjin Grand Flight Yongxuan, Tianjin Grand Flight Jimao, Ginkgo Capital. 4 distinct backers are named across the disclosed rounds.

Huisheng Biopharmaceutical at a glance

Total raised: $70M
Latest round: Series A
Latest round date: September 2022
Headquarters: Zhangjiawan, Beijing, China
Notable investors: China Life Private Equity Investment, Tianjin Grand Flight Yongxuan, Tianjin Grand Flight Jimao, Ginkgo Capital

Frequently asked about Huisheng Biopharmaceutical funding

How much has Huisheng Biopharmaceutical raised?: Huisheng Biopharmaceutical has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Huisheng Biopharmaceutical?: China Life Private Equity Investment, Tianjin Grand Flight Yongxuan, Tianjin Grand Flight Jimao, Ginkgo Capital are named among the investors backing Huisheng Biopharmaceutical.
What was the latest Huisheng Biopharmaceutical funding round?: The most recent disclosed round is a Series A, announced in September 2022.
Where is Huisheng Biopharmaceutical based?: Huisheng Biopharmaceutical is based in Zhangjiawan, Beijing, China.
When did Huisheng Biopharmaceutical last raise?: The last disclosed Huisheng Biopharmaceutical round closed in September 2022 at Series A.

Huisheng Biopharmaceutical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Zhangjiawan below to benchmark round size and investor mix.

Huisheng Biopharmaceutical Funding: $70M Raised, Series A

Huisheng Biopharmaceutical funding overview

Huisheng Biopharmaceutical at a glance

Frequently asked about Huisheng Biopharmaceutical funding

Companies related to Huisheng Biopharmaceutical (33)

Browse related funding lists (3)